Notable Stocks: Royal Dutch Shell plc (ADR) (NYSE:RDS.A), Abraxas Petroleum Corp. (NASDAQ:AXAS), Johnson & Johnson (NYSE:JNJ)

Notable Stocks: Royal Dutch Shell plc (ADR) (NYSE:RDS.A), Abraxas Petroleum Corp. (NASDAQ:AXAS), Johnson & Johnson (NYSE:JNJ)

- in Business & Finance
0

On Monday, Shares of Royal Dutch Shell plc (ADR) (NYSE:RDS.A), lost -0.95% to $45.82.

Royal Dutch Shell plc, published a circular and a prospectus for the recommended combination with BG Group plc (“BG”), ahead of a General Meeting, planned for 10:00 (Central European Time) on Wednesday 27 January 2016 at the Circustheater, Circusstraat 4, 2586 CW The Hague, The Netherlands. In addition, BG has published a scheme document ahead of its shareholder meetings.

Royal Dutch Shell plc operates as an independent oil and gas company worldwide. It operates through Upstream and Downstream segments. The company explores for and extracts crude oil, natural gas, and natural gas liquids. It also converts natural gas to liquids to provide fuels and other products; markets and trades natural gas; extracts bitumen from mined oil sands and converts it to synthetic crude oil; and generates electricity from wind energy.

Shares of Abraxas Petroleum Corp. (NASDAQ:AXAS), inclined 9.52% to $1.15, during its last trading session.

Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Abraxas Petroleum Corp. (AXAS), Sportsman’s Warehouse Holdings Inc. (SPWH), FormFactor Inc. (FORM) and Nautilus Inc. (NLS). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.

Highlights from recently’s reports comprise:

On Wednesday, December 23, 2015, NASDAQ Composite ended at 5,045.93 up 0.90%, Dow Jones Industrial Average advanced 1.06% to finish the day at 17,602.61 and the S&P 500 closed at 2,064.29, up 1.24%.

Abraxas Petroleum Corp.’s stock raised by 17.09% to close Wednesday’s session at USD 1.02. The stock traded below its 50-day and 200-day moving averages of USD 1.34 and USD 2.24, respectively. The company’s shares fluctuated in the range of USD 0.88 and USD 1.03. A total of 0.83 million shares exchanged hands, which surpassed its 50-day daily average volume of 0.81 million shares and was below its 52-week average volume of 1.49 million shares. Over the last three days Abraxas Petroleum Corp.’s shares have advanced 14.61% and in the past one week the stock has moved up 11.60%. However, over the last three months the stock has lost 21.54% and in the past six months the shares have shed 67.20%. The stock is trading at a price to book ratio of 0.61, as against the historical PB ratio of 1.50. Additionally, the stock is trading at a price to cash flow ratio of 1.71.

Abraxas Petroleum Corporation, an independent energy company, engages in the acquisition, exploitation, development, and production of oil and gas properties in the United States. The company operates oil and gas assets in the Rocky Mountain, Permian Basin, and onshore Gulf Coast regions.

Finally, Johnson & Johnson (NYSE:JNJ), ended its last trade with -0.49% loss, and closed at $103.21.

Johnson & Johnson (JNJ) will take part in the 34th Annual JP Morgan Health Care Conference on Monday, Jan. 11, at the Westin St. Francis in San Francisco. Alex Gorsky, Chairman of the Board of Directors and Chief Executive Officer, will represent the Company in a session planned at 2:30 p.m. (Pacific Time)/5:30 p.m. (Eastern Time).

Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.

Leave a Reply

Your email address will not be published. Required fields are marked *